Tandem Diabetes Care (Nasdaq: TNDM) has named its next president and CEO, as current chief John Sheridan plans to retire at the end of this year. Jeannette Bankes will lead the company starting Nov. 16. Most recently president and CEO of GE HealthCare’s patient care solutions business, Bankes has also served as a senior vice […]
Featured
MiniMed names new CMO ahead of planned retirement
MiniMed (Nasdaq: MMED) has named a new chief medical officer, as its current leader plans to retire at the end of next year. Dr. David Segal takes over for Dr. Robert Vigersky, who will now move into an emeritus position after holding the title of CMO since 2019 — back when the newly independent company […]
Insulet earnings trounce Q3 estimates as it narrows guidance
Insulet’s (Nasdaq: PODD) third quarter outpaced its own expectations and those of Wall Street, boosted by international sales of its Omnipod 5 tubeless insulin pump. Total revenue reached $842.0 million, for a 19.6% gain over the prior year, topping the company’s previous guidance and analysts’ estimates of $832.6 million. The U.S. haul accounted for $570.4 […]
Dexcom Q3 earnings top forecasts, as it looks ahead to type 2 coverage
Dexcom (Nasdaq:DXCM) topped Wall Street’s expectations for third-quarter earnings, and the company nudged up its guidance for the remainder of the year as it looks ahead to a potential Medicare coverage decision that could expand the company’s reach in type 2 diabetes. Revenue reached $1.34 billion for an 11% gain over the prior year. U.S. […]
Sensonics launches human feasibility study for transmitter-free Eversense CGM
Senseonics (NYSE: SENS) has launched its first clinical study of a transmitter-free version of its Eversense 365 continuous glucose monitor. The first-in-human trial of its Freedom system will evaluate a one-year, under-the-skin sensor that links directly with the user’s smartphone, doing away with the need for additional on-body hardware and making a CGM as discreet […]
Sequel Med Tech’s automated twiist pump scores FDA clearance in type 2 diabetes
Sequel Med Tech‘s twiist automated insulin delivery system obtained an FDA clearance opening up its use to adults with type 2 diabetes. Launched earlier this year for people with type 1 diabetes, the company estimates the agency’s green light adds about 5.5 million people in the U.S. who manage their condition with insulin. Available through […]
MiniMed completes split from Medtronic
MiniMed (Nasdaq: MMED) is celebrating its first day as an independent diabetes tech company, with the full completion of its spinoff from the Medtronic mothership. This week Medtronic reported the final results of its exchange offer for MiniMed stock, where it divested all of its remaining equity stake in the company through the swapping of […]
BD’s IV catheters plant in Utah marks 70 years
BD (NYSE:BDX) is celebrating the 70th birthday of its major manufacturing facility in Utah, which the company said produces billions of molded components each year. Located in the town of Sandy just south of Salt Lake City, the site was founded in 1956 under Deseret Pharmaceuticals. BD acquired the plant in 1986, and today it’s […]
Novo taps Nanexa for long-acting obesity injectables with €1.17B pact
Novo (NYSE: NVO) has tapped the Swedish drug-delivery developer Nanexa to develop long-acting injectable platforms for its peptide meds, with a global licensing deal worth €1.165 billion, or about $1.32 billion U.S. The deal will support up to five R&D programs targeting monthly and quarterly injections, as the drugmaker looks to extend the reach of […]
Abbott partners with Berry Street to add nutrition coaching to Lingo
Abbott (NYSE: ABT) is teaming up with Berry Street to offer dietitian support programs to Lingo users. Wearers of the over-the-counter continuous glucose monitor can now sign up for personalized nutrition coaching linked to their data trends, and schedule virtual one-on-one appointments with registered and insurance-covered dietitians. At the same time, Berry Street users will […]
